28,933 resources
By Version
By Authority
By Realm
Start Prev Rows 1400 - 1600 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.642 | T2DM_Medications Allergy RXNORM | active | 2023-09 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.643 | T2DM_Medications Allergy SNOMED | active | 2023-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.646 | T2DM_Medication Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.647 | Statins Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.649 | ACE Inhibitors Allergy Intolerance | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.650 | ARB Allergy Intolerance | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.652 | Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.653 | Long Acting Beta Agonists (LABA) Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.654 | BetaBlocker NonCS Secondary Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.656 | MRA Allergy Intolerance | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.657 | Eplerenone Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.658 | Spironolactone Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.659 | SGLT2i Allergy Intolerance | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.660 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.661 | Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.665 | Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.666 | Human Papillomavirus (HPV) vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.667 | Herpes Zoster Vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.670 | Pneumococcal Vaccine Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.671 | Inhaled Corticosteroids(ICS) Allergy Intolerance | active | 2023-09 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.672 | LABA(Formoterol only) | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.674 | PIM_Tirzepatide | active | 2023-09 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.675 | GLP1RA Allergy Intolerance | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.676 | PIM_Diabetes_Testing_Supplies | active | 2025-05 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.677 | PIM_H2_Antagonists | active | 2023-09 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.678 | SGLT2i DM CKD | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.679 | SGLT2i DM ASCVD | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.683 | OIA_Gout_Medications | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.684 | GlumetzaSubstitution | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.685 | MetforminER500mg | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.686 | PIM_Metformin | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.687 | PIM_Glipizide | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.689 | PIM_Glipizide_Glyburide_Glimepiride | active | 2024-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.690 | PIM_Insulin_Meglitinides | active | 2023-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.691 | PIM_Glyxambi | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.692 | PIM_Farxiga | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.693 | PIM_Invokana | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.694 | PIM_Jardiance | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.695 | PIM_Invokana_Jardiance | active | 2023-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.696 | Reclast | active | 2023-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.697 | LAMA_LABA Combination 1 Inhaler | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.698 | PIM_Contraceptives | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.699 | Selected Oral Antiemetics for Migraine | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.700 | PIM_DEXA_Scan | active | 2023-12 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.701 | PIM_DEXA_Scan_CPT_LOINC | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.702 | PIM_SSRIs | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.703 | PIM_SNRIs | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.704 | PIM_NRIs | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.705 | PIM_TCAs | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.706 | PIM_Citalopram | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.707 | PIM_Hydroxyzine | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.708 | PIM_Buspirone | active | 2023-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.709 | PIM_Bupropion | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.710 | PIM_Mirtazapine | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.711 | PIM_Trazodone | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.712 | PIM_IHD_CHD_CAD_ICD10 | active | 2023-11 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.713 | PIM_IHD_CHD_CAD_SNOMED | active | 2023-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.714 | PIM_Gabapentin | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.715 | PIM_Allergy_Nasal_Sprays | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.716 | PIM_Allergy_Oral_Meds | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.717 | PIM_Allergy_Nasal_Oral | active | 2023-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.719 | OCS_Prednisolone | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.72 | Inhaled corticosteroids (IC) | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.720 | COPD_Ofloxacin | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.721 | COPD_Ciprofloxacin | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.722 | COPD_Doxycycline | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.723 | Macrolide Allergy SCT | active | 2023-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.724 | Macrolide Allergy Intolerance | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.725 | Prednisone Allergy SCT | active | 2023-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.727 | Tetracycline Allergy SCT | active | 2023-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.728 | Tetracycline Allergy Intolerance | active | 2023-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.729 | Fluoroquinolones Allergy SCT | active | 2023-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.730 | Fluoroquinolone Allergy Intolerance | active | 2023-11 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.731 | Penicillin Allergy RXNORM | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.732 | Penicillin Allergy SCT | active | 2023-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.733 | Penicillin Allergy Intolerance | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.734 | PIM_Metformin_Single_Ingredient_Only | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.735 | PIM_Metformin_Combo_Ingredient_Only | active | 2023-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.737 | Pneumonia SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.738 | Pneumonia | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.739 | Pulmonary Embolism I10 | active | 2023-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.742 | Pulmonary Embolism SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.743 | Pulmonary Embolism | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.744 | Influenza I10 | active | 2023-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.745 | Influenza SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.746 | Influenza (Tests for influenza A or B virus Antigen) | active | 2023-12 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.747 | Influenza | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.748 | COVID 19 I10 | active | 2023-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.749 | COVID19 SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.750 | COVID19 | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.752 | RSV I10 | active | 2023-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.753 | RSV SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.754 | RSV | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.755 | Respiratory Rate SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.756 | Respiratory Rate LOINC | active | 2024-09 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.757 | Respiratory Rate | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.758 | Acute Respiratory Failure I10 | active | 2023-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.759 | Acute Respiratory Failure SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.760 | Acute Respiratory Failure | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.761 | Dyspnea SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.762 | Dyspnea I10 | active | 2023-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.763 | Dyspnea | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.764 | Confusion I10 | active | 2023-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.765 | Confusion SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.766 | Confusion | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.767 | Drowsiness SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.768 | Drowsiness I10 | active | 2023-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.769 | Drowsiness | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.770 | Cyanosis I10 | active | 2023-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.771 | Cyanosis SCT | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.772 | Cyanosis | active | 2023-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.775 | Arterial oxygen saturation LOINC | active | 2024-09 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.776 | Arterial oxygen saturation SCT | active | 2024-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation | active | 2024-08 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.779 | PIM_Potassium_Supplements | active | 2024-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.780 | PIM_PPIs | active | 2024-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.781 | PIM_Migraine_Medications_Abortive | active | 2024-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.782 | PIM_Migraine_Medications_Preventive | active | 2024-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.783 | PIM_Bisphosphonates | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.784 | PIM_BPH_Medications | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.785 | PIM_Thyroid_Replacement_Medications | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.786 | PIM_Overactive_Bladder_Medications | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.787 | PIM_Topical_Acne_Medications | active | 2024-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.788 | PIM_Antidepressant_Anxiolytic_Medications | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.789 | Simple Knee Pain I10 | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.790 | Simple Knee Pain SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.791 | Simple Knee Pain | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.792 | Simple Left Knee Pain SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.793 | Simple Right Knee Pain SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.794 | Simple Right Knee Pain I10 | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.795 | Simple Left Knee Pain I10 | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.796 | Simple Right Knee Pain | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.797 | Simple Left Knee pain | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.798 | Knee joint surgery CPT | active | 2024-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.799 | Knee joint surgery SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.800 | Knee joint surgery | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.801 | Knee Osteoarthritis I10 | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.802 | Knee Osteoarthritis SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.803 | Knee Osteoarthritis | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.804 | Osteoarthritis of right knee SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.805 | Osteoarthritis of left knee SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.806 | Osteoarthritis of right knee I10 | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.807 | Osteoarthritis of left knee I10 | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.808 | Osteoarthritis of right knee | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.809 | Osteoarthritis of left knee | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.810 | Hip Osteoarthritis SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.811 | Hip Osteoarthritis I10 | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.812 | Hip Osteoarthritis | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.813 | Hip joint surgery CPT | active | 2024-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.814 | Hip joint surgery SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.815 | Hip joint surgery | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.816 | Osteoarthritis of right hip I10 | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.817 | Osteoarthritis of left hip I10 | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.818 | Osteoarthritis of right hip SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.819 | Osteoarthritis of left hip SCT | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.820 | Osteoarthritis of right hip | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.821 | Osteoarthritis of left hip | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.823 | Aminoglycosides | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.824 | Carbapenems | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.826 | Monobactams | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.827 | Penicillins | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.828 | Antimycobacterials | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.829 | Beta_lactamase | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.830 | Cyclic lipopeptides | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.831 | Lincosamides | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.832 | Macrolides | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.833 | Amphenicol | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.834 | Oxazolidinones | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.835 | Fluoroquinolones | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.836 | Sulfonamides | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.837 | Tetracyclines | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.838 | Phosphonics | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.839 | Pleuromutilin | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.840 | Streptogramins | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.841 | Lipoglycopeptides | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.842 | Nitroimidazoles | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.843 | PIM_Hyd_Bus_Mir_Tra | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.844 | Nitrofurans | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.845 | Rifamycins | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.846 | Glycylcycline | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.847 | Pyrimidines | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.849 | Antibiotics oral and parenteral | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.850 | Medications_hyperkalemia | active | 2024-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.852 | Hyperkalemia_ICD10 | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.853 | Hyperkalemia_SCT | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.854 | Hyperkalemia Conditions | active | 2024-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.855 | Medications_Chronic Hyperkalemia | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.858 | PIM_Alpha_Blockers_2 | active | 2024-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.860 | PIM_Ambulatory_Visits_CPTs | active | 2024-03 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.862 | PIM_Ambulatory_Visits_SNOMED | active | 2024-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.863 | PIM_Thyroid_Stimulating_Hormone_(TSH) | active | 2024-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.864 | PIM_Triiodothyronine_(T3) | active | 2024-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.865 | PIM_Thyroxine_(T4) | active | 2024-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.866 | PIM_Magnesium_LOINC | active | 2024-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.867 | PIM_BMP_CMP_LOINC | active | 2024-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.868 | PIM_URIC_ACID_LOINC | active | 2024-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.869 | PIM_Migraine_Medications | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.870 | PIM_Triptans | active | 2024-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.871 | ICS_SABA Reliever | active | 2024-06 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.873 | PIM_Asthma_COPD_Meds | active | 2025-03 | us | hl7 | rx |